What to Make of the GLP-1 Coverage and Cost Landscape
How payers are handling the rise of GLP-1s? Cost and clinical transparency can support whatever strategy a plan takes.
What to Make of the GLP-1 Coverage and Cost Landscape Read More »
Chronic Conditions
The Great 2023 Humira Biosimilars Watch Is On – Here’s Where to Focus
Up to 10 competing products for Humira are on the way in 2023. What should health plans and plan sponsors be following as the biosimilars landscape takes shape?
The Great 2023 Humira Biosimilars Watch Is On – Here’s Where to Focus Read More »
Diabetes by the Numbers, and the Importance of Affordable Medication
Some lesser-known facts about this chronic condition underscore the importance of medication adherence, and the positive impact RxSS can have on members with diabetes.
Diabetes by the Numbers, and the Importance of Affordable Medication Read More »
